InsiderTrades

Form 4 for RLMD RELMADA THERAPEUTICS, INC.

Accepted 2025-08-28 00:00:00 ET · period of report 2025-08-26 · accession 0001213900-25-081837 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-08-28 2025-08-26+ RLMD TRAVERSA SERGIO CEO, Dir P - Purchase $0.6696 +266.0K 944.0K +39% +$178.1K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-26 P A 80,545 $0.62 814,569 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F2) Purchase prices range from $0.61 to $0.65 per share, inclusive.
2 Common Common Stock 2025-08-28 P A 55,976 $0.74 1,000,000 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F4) Purchase prices range from $0.68 to $0.79 per share, inclusive.
3 Common Common Stock 2025-08-27 P A 129,455 $0.67 944,024 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F3) Purchase prices range from $0.65 to $0.69 per share, inclusive.